| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2026 | 3. Issuer Name and Ticker or Trading Symbol
Bank7 Corp. [ BSVN ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common stock, par value $0.01 per share | 7,497(1)(2)(3) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Options | (4) | 09/19/2028 | Common stock, par value $0.01 per share | 10,000 | $19 | D | |
| Employee Stock Options | (5) | 01/06/2030 | Common stock, par value $0.01 per share | 1,750 | $18.49 | D | |
| Employee Stock Options | (6) | 01/04/2031 | Common stock, par value $0.01 per share | 1,000 | $14.39 | D | |
| Explanation of Responses: |
| 1. Includes 2,625 restricted stock units. The original grant of 3,500 restricted stock units vests in four equal installments on February 15, 2026, 2027, 2028, and 2029. |
| 2. Includes 2,000 restricted stock units. The original grant of 4,000 restricted stock units vests in four equal installments on February 15, 2025, 2026, 2027, and 2028. |
| 3. Includes 1,250 restricted stock units. The original grant of 5,000 restricted stock units vests in four equal installments on February 15, 2024, 2025, 2026, and 2027. |
| 4. Represents a grant of employee stock options, which vested in four equal installments on September 19, 2029, 2020, 2021, and 2022. |
| 5. Represents a grant of employee stock options, which vested in four equal installments on January 6, 2021, 2022, 2023, and 2024. |
| 6. Represents a grant of employee stock options, which vested in four equal installments on January 4, 2022, 2023, 2024, and 2025. |
| Henry C. Litchfield, Attorney-In-Fact | 03/26/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||